Lilly(Eli) & Company
NYSE: LLY
$789.32
+$34.32 (+4.5%)
Closing Price on November 26, 2024
LLY Articles
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Loxo shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly. The transaction is not subject to any financing condition and is expected to close by...
Published:
Last Updated:
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday included Altbaba, AutoDesk, AutoZone, CBS, Eli Lilly, Lululemon, Michael's and Target.
Published:
Last Updated:
Eli Lilly shares were slightly lower after the company announced positive results from its late-stage active psoriatic arthritis study.
Published:
Last Updated:
Eli Lilly shares rose slightly on Thursday after the company announced an FDA update on its treatment for systemic lupus erythematosus.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday included American Eagle Outfitters, Eli Lilly, GameStop, Intuit, Novavax, Nvidia, Salesforce.com and Schlumberger.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Published:
Last Updated:
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
Published:
Last Updated:
Eli Lilly released better-than-expected third-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Eli Lilly is scheduled to release its most recent quarterly results before the markets open on Tuesday.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aetna, Baker Hughes, Chesapeake Energy, Cognizant Technology Solutions, Cummins, Eli Lilly, General Electric, Qualcomm...
Published:
Last Updated: